NASDAQ · Medical - Instruments & Supplies

POCI (POCI) Stock

$4.24 +1.92% NASDAQ: POCI Healthcare

Valuation

MetricValue
Price$4.24
Market Cap$32.76M
P/E Ratio-5.93
P/B Ratio3.25
P/S Ratio1.35
EPS (TTM)$-0.85
52-Week High$6.15
52-Week Low$3.55
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-50.00%
ROA-30.00%
ROCE-50.00%
Gross Margin-31.58%
Operating Margin-31.58%
Net Margin-17.03%
Debt/Equity0.21
Current Ratio1.67

Annual Financials (USD)

Metric20212022202320242025
Revenue$11.0M$16.0M$21.0M$19.0M$19.0M
Operating Profit$-1.0M$-1.0M$-1.0M$-3.0M$-6.0M
Net Profit$0$-1.0M$0$-3.0M$-6.0M
EPS$-0.02$-0.18$-0.03$-0.49$-0.85
Op Margin-8.5%-8.6%-3.0%-14.3%-29.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$6.0M$17.0M$20.0M$17.0M$20.0M
Total Liabilities$3.0M$8.0M$8.0M$7.0M$8.0M
Cash$1.0M$1.0M$3.0M$0$2.0M
Borrowings$0$3.0M$3.0M$3.0M$2.0M

Latest News

Precision Optics to Present at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17, 2026 GlobeNewswire · Jun 9, 2026 Precision Optics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026 GlobeNewswire · May 18, 2026 Precision Optics Corporation (POCI) Stock Surges Over 23% Overnight: Why Is It Moving? Benzinga · May 14, 2026 Precision Optics Corp Inc (POCI) Q3 2026 Earnings Call Highlights: Record Revenue and Strategic ... GuruFocus.com · May 14, 2026 POCI Q3 2026 Earnings Transcript Motley Fool · May 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$-1.0M$0$-3.0M$-4.0M
Investing Cash Flow$0$-1.0M$0$-1.0M$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$0$2.0M$-3.0M$1.0M
Free Cash Flow$0$-1.0M$0$-3.0M$-4.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-4.81%
Quick Ratio1.74
Interest Coverage—
Return 1Y0.63%
Return 3Y-18.29%
Return 5Y-3.43%

Ownership

Insiders Held20.98%
Institutions Held43.73%
Institutions Float Held55.33%
Institutional HolderSharesReport Date
Needham Investment Management, L.L.C.1,670,5502026-03-31
MYDA Advisors LLC400,0002026-03-31
Nantahala Capital Management, LLC280,0002026-03-31
Bleichroeder LP270,9252026-03-31
Wealthtrust Axiom, LLC254,1082026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About POCI

POCI is led by CEO Joseph N. Forkey, employs 83 people, headquartered in US, publicly traded since 1992.

POCI stock trades at $4.24 with a market capitalization of $32.76M. The stock is valued at a price-to-earnings (P/E) ratio of -5.93, price-to-book of 3.25, price-to-sales of 1.35. Over the past 52 weeks the stock has ranged between $3.55 and $6.15, and currently trades 31.1% below its 52-week high.

On profitability, POCI generates a return on equity (ROE) of -50.00%, return on capital employed of -50.00%, an operating margin of -31.58%, a net profit margin of -17.03%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides